Global Peripheral Vascular Stents Market 2017-2021
About Peripheral Vascular Stents
Peripheral vascular stents are most commonly used in treating conditions called as PVDs. It is crampy leg pain that occurs during walking and exercise. It occurs in individuals aged 65 and above and is the result of atherosclerosis (hardening of the arteries), which occurs due to scar tissue and cholesterol build up, forming a substance called plaque inside the arteries.
Technavio’s analysts forecast the global peripheral vascular stents market to grow at a CAGR of 7.96% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global peripheral vascular stents market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Peripheral Vascular Stents Market 2017-2021
Technavio recognizes the following companies as the key players in the global peripheral vascular stents market: Boston Scientific, Abbott, Medtronic, Cook, C. R. Bard, BIOTRONIK, and Cordis (a Cardinal Health company).
Other Prominent Vendors in the market are: 480 Biomedical, Alvimedica, B. Braun Melsungen, Balton, Bentley, Biosensors International Group, ENDOCOR, eucatech, InSitu Technologies, InspireMD, iVascular, KYOTO MEDICAL PLANNING, Meril Life Sciences, optimed, PanMed US, RONTIS, Terumo Medical, Veryan Medical, and W. L. Gore & Associates.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Technology caters the pace for advances in stenting. Peripheral vascular stents play a key role in the treatment of PADs and restenosis. In the last decade, there has been a continuous focus on technological advances in terms of design and materials to prevent the narrowing of a blood vessel and to improve long-term effectivity.”
According to the report, one of the major drivers for this market is Ubiquity of PAD. The global prevalence of PAD increased by a significant percentage in the last decade. Approximately one-fourth of the world's population has PAD, and the number is increasing in developing economies. The growing prevalence of PAD is the primary factor involved in the higher sales of peripheral vascular stents. The prevalence of PAD among the developed nations is as similar as the developing nations.
Further, the report states that one of the major factors hindering the growth of this market is Risks and complications associated with peripheral vascular stents. Although angioplasty and vascular stenting are the standard procedures to be followed, there are some risks and complications associated with the peripheral vascular stents. The primary complications associated with the usage of peripheral stents are the reoccurrence of stenosis and thrombosis. The procedure consists of minor and major complications associated with stentings, such as perforation, stent migration, fever, intra-procedural complications, and in few cases, allergic reactions to medication or dye.
Boston Scientific, Abbott, Medtronic, Cook, C. R. Bard, BIOTRONIK, Cordis (a Cardinal Health company), 480 Biomedical, Alvimedica, B. Braun Melsungen, Balton, Bentley, Biosensors International Group, ENDOCOR, eucatech, InSitu Technologies, InspireMD, iVascular, KYOTO MEDICAL PLANNING, Meril Life Sciences, optimed, PanMed US, RONTIS, Terumo Medical, Veryan Medical, and W. L. Gore & Associates.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook